AbbVie Fights IRS Nix Of Deduction For $1.6B Merger Fee

By David van den Berg · March 9, 2023, 6:57 PM EST

Pharmaceutical giant AbbVie is challenging the IRS' denial of its claimed deduction for a $1.6 billion break fee payment to Irish biotechnology company Shire over their failed merger, telling the U.S....

To view the full article, register now.